(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of MAP4K4 mRNA] CTD PMID:31150632 (-)-demecolcine increases expression ISO MAP4K4 (Homo sapiens) 6480464 Demecolcine results in increased expression of MAP4K4 mRNA CTD PMID:23649840 (1->4)-beta-D-glucan multiple interactions ISO Map4k4 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MAP4K4 mRNA CTD PMID:36331819 1,1-dichloroethene increases expression ISO Map4k4 (Mus musculus) 6480464 vinylidene chloride results in increased expression of MAP4K4 mRNA CTD PMID:26682919 1,2-dimethylhydrazine increases expression ISO Map4k4 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in increased expression of MAP4K4 mRNA CTD PMID:22206623 17beta-estradiol multiple interactions ISO MAP4K4 (Homo sapiens) 6480464 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of MAP4K4 mRNA and [Estradiol co-treated with Progesterone] results in decreased expression of MAP4K4 mRNA CTD PMID:20660070 and PMID:20823114 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Map4k4 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with AHR gene mutant form] results in decreased expression of MAP4K4 mRNA CTD PMID:19465110 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of MAP4K4 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of MAP4K4 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Map4k4 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of MAP4K4 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO MAP4K4 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in decreased expression of MAP4K4 mRNA CTD PMID:20106945 and PMID:21632981 4,4'-sulfonyldiphenol increases expression ISO Map4k4 (Mus musculus) 6480464 bisphenol S results in increased expression of MAP4K4 mRNA CTD PMID:33297965 4,4'-sulfonyldiphenol increases expression ISO MAP4K4 (Homo sapiens) 6480464 bisphenol S results in increased expression of MAP4K4 protein CTD PMID:34186270 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of MAP4K4 mRNA CTD PMID:36041667 4-hydroxyphenyl retinamide increases expression ISO Map4k4 (Mus musculus) 6480464 Fenretinide results in increased expression of MAP4K4 mRNA CTD PMID:28973697 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of MAP4K4 mRNA CTD PMID:24780913 acetamide increases expression EXP 6480464 acetamide results in increased expression of MAP4K4 mRNA CTD PMID:31881176 acetylsalicylic acid decreases expression ISO MAP4K4 (Homo sapiens) 6480464 Aspirin results in decreased expression of MAP4K4 mRNA CTD PMID:15928584 aconitine increases expression EXP 6480464 Aconitine results in increased expression of MAP4K4 protein CTD PMID:33236894 acrolein multiple interactions ISO MAP4K4 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of MAP4K4 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of MAP4K4 mRNA CTD PMID:32699268 aflatoxin B1 increases expression ISO Map4k4 (Mus musculus) 6480464 Aflatoxin B1 results in increased expression of MAP4K4 mRNA CTD PMID:19770486 aflatoxin B1 increases methylation ISO MAP4K4 (Homo sapiens) 6480464 Aflatoxin B1 results in increased methylation of MAP4K4 exon CTD PMID:30157460 all-trans-retinoic acid decreases expression ISO MAP4K4 (Homo sapiens) 6480464 Tretinoin results in decreased expression of MAP4K4 mRNA CTD PMID:33167477 alpha-pinene multiple interactions ISO MAP4K4 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of MAP4K4 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of MAP4K4 mRNA CTD PMID:32699268 amphetamine decreases expression EXP 6480464 Amphetamine results in decreased expression of MAP4K4 mRNA CTD PMID:30779732 antirheumatic drug increases expression ISO MAP4K4 (Homo sapiens) 6480464 Antirheumatic Agents results in increased expression of MAP4K4 mRNA CTD PMID:24449571 arsenite(3-) multiple interactions ISO MAP4K4 (Homo sapiens) 6480464 arsenite inhibits the reaction [G3BP1 protein binds to MAP4K4 mRNA] CTD PMID:32406909 benzo[a]pyrene increases expression ISO Map4k4 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of MAP4K4 mRNA CTD PMID:19770486 more ... benzo[a]pyrene increases expression ISO MAP4K4 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of MAP4K4 mRNA CTD PMID:32234424 benzo[a]pyrene affects methylation ISO MAP4K4 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of MAP4K4 promoter CTD PMID:27901495 benzo[a]pyrene multiple interactions ISO Map4k4 (Mus musculus) 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MAP4K4 mRNA CTD PMID:27858113 benzo[a]pyrene decreases expression ISO MAP4K4 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of MAP4K4 mRNA CTD PMID:20106945 more ... benzo[a]pyrene diol epoxide I decreases expression ISO MAP4K4 (Homo sapiens) 6480464 7 more ... CTD PMID:19150397 benzo[b]fluoranthene increases expression ISO Map4k4 (Mus musculus) 6480464 benzo(b)fluoranthene results in increased expression of MAP4K4 mRNA CTD PMID:26377693 benzo[b]fluoranthene multiple interactions ISO Map4k4 (Mus musculus) 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MAP4K4 mRNA CTD PMID:27858113 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of MAP4K4 mRNA CTD PMID:25181051 more ... bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of MAP4K4 mRNA CTD PMID:36041667 bisphenol A increases expression ISO MAP4K4 (Homo sapiens) 6480464 bisphenol A results in increased expression of MAP4K4 protein CTD PMID:34186270 bisphenol A decreases expression ISO Map4k4 (Mus musculus) 6480464 bisphenol A results in decreased expression of MAP4K4 mRNA CTD PMID:38074096 bisphenol A multiple interactions ISO MAP4K4 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] affects the methylation of MAP4K4 gene CTD PMID:31601247 bisphenol A affects methylation ISO MAP4K4 (Homo sapiens) 6480464 bisphenol A affects the methylation of MAP4K4 gene CTD PMID:31601247 bisphenol A decreases expression ISO MAP4K4 (Homo sapiens) 6480464 bisphenol A results in decreased expression of MAP4K4 protein CTD PMID:33376534 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of MAP4K4 mRNA CTD PMID:32145629 bisphenol A affects expression ISO MAP4K4 (Homo sapiens) 6480464 bisphenol A affects the expression of MAP4K4 mRNA CTD PMID:30903817 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of MAP4K4 gene CTD PMID:28505145 bisphenol F multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of MAP4K4 mRNA CTD PMID:36041667 bortezomib increases expression ISO MAP4K4 (Homo sapiens) 6480464 Bortezomib results in increased expression of MAP4K4 mRNA CTD PMID:20977926 bucladesine multiple interactions ISO MAP4K4 (Homo sapiens) 6480464 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of MAP4K4 mRNA CTD PMID:20823114 caffeine decreases phosphorylation ISO MAP4K4 (Homo sapiens) 6480464 Caffeine results in decreased phosphorylation of MAP4K4 protein CTD PMID:35688186 cannabidiol multiple interactions ISO MAP4K4 (Homo sapiens) 6480464 [Cannabidiol co-treated with moringin] results in decreased expression of MAP4K4 mRNA CTD PMID:30096889 captan decreases expression ISO Map4k4 (Mus musculus) 6480464 Captan results in decreased expression of MAP4K4 mRNA CTD PMID:31558096 carbamazepine affects expression ISO MAP4K4 (Homo sapiens) 6480464 Carbamazepine affects the expression of MAP4K4 mRNA CTD PMID:24752500 carbon nanotube increases expression ISO Map4k4 (Mus musculus) 6480464 Nanotubes and Carbon analog results in increased expression of MAP4K4 mRNA CTD PMID:25554681 cerium trichloride increases expression ISO Map4k4 (Mus musculus) 6480464 cerous chloride results in increased expression of MAP4K4 mRNA and cerous chloride results in increased expression of MAP4K4 protein CTD PMID:21656643 chloroprene decreases expression EXP 6480464 Chloroprene results in decreased expression of MAP4K4 mRNA CTD PMID:23125180 choline multiple interactions ISO Map4k4 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MAP4K4 mRNA CTD PMID:20938992 chrysene multiple interactions ISO Map4k4 (Mus musculus) 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MAP4K4 mRNA CTD PMID:27858113 cisplatin decreases expression ISO MAP4K4 (Homo sapiens) 6480464 Cisplatin results in decreased expression of MAP4K4 mRNA CTD PMID:19561079 copper atom multiple interactions ISO MAP4K4 (Homo sapiens) 6480464 [Chelating Agents binds to Copper] which results in increased expression of MAP4K4 mRNA CTD PMID:30911355 copper(0) multiple interactions ISO MAP4K4 (Homo sapiens) 6480464 [Chelating Agents binds to Copper] which results in increased expression of MAP4K4 mRNA CTD PMID:30911355 copper(II) sulfate decreases expression ISO MAP4K4 (Homo sapiens) 6480464 Copper Sulfate results in decreased expression of MAP4K4 mRNA CTD PMID:19549813 coumarin decreases phosphorylation ISO MAP4K4 (Homo sapiens) 6480464 coumarin results in decreased phosphorylation of MAP4K4 protein CTD PMID:35688186 coumestrol multiple interactions ISO MAP4K4 (Homo sapiens) 6480464 [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MAP4K4 mRNA CTD PMID:19167446 coumestrol decreases expression ISO MAP4K4 (Homo sapiens) 6480464 Coumestrol results in decreased expression of MAP4K4 mRNA CTD PMID:19167446 cyclosporin A decreases expression ISO MAP4K4 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of MAP4K4 mRNA CTD PMID:25562108 and PMID:27989131 dibenz[a,h]anthracene increases expression ISO Map4k4 (Mus musculus) 6480464 1 more ... CTD PMID:26377693 dibenzo[a,l]pyrene decreases expression ISO Map4k4 (Mus musculus) 6480464 dibenzo(a and l)pyrene results in decreased expression of MAP4K4 mRNA CTD PMID:25908611 diclofenac affects expression ISO MAP4K4 (Homo sapiens) 6480464 Diclofenac affects the expression of MAP4K4 mRNA CTD PMID:24752500 diuron decreases expression ISO MAP4K4 (Homo sapiens) 6480464 Diuron results in decreased expression of MAP4K4 mRNA CTD PMID:35967413 dorsomorphin multiple interactions ISO MAP4K4 (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAP4K4 mRNA CTD PMID:27188386 doxorubicin increases expression ISO MAP4K4 (Homo sapiens) 6480464 Doxorubicin results in increased expression of MAP4K4 mRNA CTD PMID:29803840 Enterolactone multiple interactions ISO MAP4K4 (Homo sapiens) 6480464 [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MAP4K4 mRNA CTD PMID:19167446 epoxiconazole increases expression ISO Map4k4 (Mus musculus) 6480464 epoxiconazole results in increased expression of MAP4K4 mRNA CTD PMID:35436446 ethanol affects splicing ISO Map4k4 (Mus musculus) 6480464 Ethanol affects the splicing of MAP4K4 mRNA CTD PMID:30319688 ethanol multiple interactions ISO Map4k4 (Mus musculus) 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of MAP4K4 mRNA and Ethanol affects the expression of and affects the splicing of MAP4K4 mRNA CTD PMID:30319688 and PMID:30517762 ethanol increases expression ISO Map4k4 (Mus musculus) 6480464 Ethanol results in increased expression of MAP4K4 mRNA CTD PMID:30319688 ethyl methanesulfonate increases expression ISO MAP4K4 (Homo sapiens) 6480464 Ethyl Methanesulfonate results in increased expression of MAP4K4 mRNA CTD PMID:23649840 fenthion decreases expression ISO Map4k4 (Mus musculus) 6480464 Fenthion results in decreased expression of MAP4K4 mRNA CTD PMID:34813904 fenvalerate increases expression EXP 6480464 fenvalerate results in increased expression of MAP4K4 mRNA CTD PMID:30307764 folic acid multiple interactions ISO Map4k4 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MAP4K4 mRNA CTD PMID:20938992 formaldehyde decreases expression ISO MAP4K4 (Homo sapiens) 6480464 Formaldehyde results in decreased expression of MAP4K4 mRNA CTD PMID:20655997 formaldehyde increases expression ISO MAP4K4 (Homo sapiens) 6480464 Formaldehyde results in increased expression of MAP4K4 mRNA CTD PMID:23649840 FR900359 affects phosphorylation ISO MAP4K4 (Homo sapiens) 6480464 FR900359 affects the phosphorylation of MAP4K4 protein CTD PMID:37730182 fulvestrant multiple interactions ISO MAP4K4 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] affects the methylation of MAP4K4 gene CTD PMID:31601247 furan increases methylation EXP 6480464 furan results in increased methylation of MAP4K4 gene CTD PMID:22079235 gallic acid decreases expression ISO MAP4K4 (Homo sapiens) 6480464 Gallic Acid results in decreased expression of MAP4K4 mRNA CTD PMID:34408198 gamma-hexachlorocyclohexane decreases expression EXP 6480464 Hexachlorocyclohexane results in decreased expression of MAP4K4 mRNA CTD PMID:17785943 hexadecanoic acid multiple interactions ISO MAP4K4 (Homo sapiens) 6480464 [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] results in increased expression of MAP4K4 mRNA CTD PMID:30547786 indole-3-methanol affects expression EXP 6480464 indole-3-carbinol affects the expression of MAP4K4 mRNA CTD PMID:21396975 indometacin decreases expression ISO MAP4K4 (Homo sapiens) 6480464 Indomethacin results in decreased expression of MAP4K4 mRNA CTD PMID:16984733 inulin multiple interactions ISO Map4k4 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of MAP4K4 mRNA CTD PMID:36331819 L-methionine multiple interactions ISO Map4k4 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MAP4K4 mRNA CTD PMID:20938992 lead diacetate increases expression ISO Map4k4 (Mus musculus) 6480464 lead acetate results in increased expression of MAP4K4 mRNA CTD PMID:21829687 lead(0) affects splicing ISO MAP4K4 (Homo sapiens) 6480464 Lead affects the splicing of MAP4K4 mRNA CTD PMID:28903495 medroxyprogesterone acetate multiple interactions ISO MAP4K4 (Homo sapiens) 6480464 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of MAP4K4 mRNA CTD PMID:20823114 menadione affects expression ISO MAP4K4 (Homo sapiens) 6480464 Vitamin K 3 affects the expression of MAP4K4 mRNA CTD PMID:20044591 mercury dibromide increases expression ISO MAP4K4 (Homo sapiens) 6480464 mercuric bromide results in increased expression of MAP4K4 mRNA CTD PMID:26272509 methotrexate increases expression ISO MAP4K4 (Homo sapiens) 6480464 Methotrexate results in increased expression of MAP4K4 mRNA CTD PMID:21678067 methyl methanesulfonate increases expression ISO MAP4K4 (Homo sapiens) 6480464 Methyl Methanesulfonate results in increased expression of MAP4K4 mRNA CTD PMID:23649840 methylmercury chloride increases expression ISO MAP4K4 (Homo sapiens) 6480464 methylmercuric chloride results in increased expression of MAP4K4 mRNA CTD PMID:23179753 and PMID:28001369 N-methyl-4-phenylpyridinium decreases expression ISO MAP4K4 (Homo sapiens) 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of MAP4K4 mRNA CTD PMID:24810058 N-nitrosodiethylamine increases expression ISO Map4k4 (Mus musculus) 6480464 Diethylnitrosamine results in increased expression of MAP4K4 mRNA CTD PMID:24535843 nickel atom increases expression ISO MAP4K4 (Homo sapiens) 6480464 Nickel results in increased expression of MAP4K4 mRNA CTD PMID:25583101 nitrates increases expression EXP 6480464 Nitrates results in increased expression of MAP4K4 mRNA CTD PMID:30022042 ochratoxin A decreases expression ISO MAP4K4 (Homo sapiens) 6480464 ochratoxin A results in decreased expression of MAP4K4 mRNA CTD PMID:30559759 oleic acid multiple interactions ISO MAP4K4 (Homo sapiens) 6480464 [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] results in increased expression of MAP4K4 mRNA CTD PMID:30547786 orphenadrine affects expression EXP 6480464 Orphenadrine affects the expression of MAP4K4 mRNA CTD PMID:23665939 oxaliplatin increases expression EXP 6480464 oxaliplatin results in increased expression of MAP4K4 mRNA CTD PMID:25729387 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of MAP4K4 mRNA CTD PMID:25729387 ozone multiple interactions ISO MAP4K4 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of MAP4K4 mRNA more ... CTD PMID:32699268 and PMID:35430440 paracetamol affects expression ISO Map4k4 (Mus musculus) 6480464 Acetaminophen affects the expression of MAP4K4 mRNA CTD PMID:17562736 perfluorohexanesulfonic acid decreases expression ISO Map4k4 (Mus musculus) 6480464 perfluorohexanesulfonic acid results in decreased expression of MAP4K4 mRNA CTD PMID:37995155 perfluorooctane-1-sulfonic acid multiple interactions ISO Map4k4 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MAP4K4 mRNA and [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of MAP4K4 mRNA CTD PMID:36331819 pirinixic acid multiple interactions ISO Map4k4 (Mus musculus) 6480464 PPARA protein affects the reaction [pirinixic acid results in increased expression of MAP4K4 mRNA] CTD PMID:21318169 pirinixic acid increases expression ISO Map4k4 (Mus musculus) 6480464 pirinixic acid results in increased expression of MAP4K4 mRNA CTD PMID:18301758 more ... potassium dichromate decreases expression ISO Map4k4 (Mus musculus) 6480464 Potassium Dichromate results in decreased expression of MAP4K4 mRNA CTD PMID:23608068 progesterone multiple interactions ISO MAP4K4 (Homo sapiens) 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of MAP4K4 mRNA CTD PMID:20660070 quercetin decreases expression ISO MAP4K4 (Homo sapiens) 6480464 Quercetin results in decreased expression of MAP4K4 mRNA CTD PMID:21632981 resveratrol multiple interactions ISO MAP4K4 (Homo sapiens) 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of MAP4K4 mRNA CTD PMID:23557933 SB 431542 multiple interactions ISO MAP4K4 (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAP4K4 mRNA CTD PMID:27188386 sertraline multiple interactions ISO MAP4K4 (Homo sapiens) 6480464 MAP4K4 mutant form inhibits the reaction [Sertraline results in increased cleavage of CASP4 protein] more ... CTD PMID:24865413 sertraline decreases expression ISO MAP4K4 (Homo sapiens) 6480464 Sertraline results in decreased expression of MAP4K4 mRNA CTD PMID:24865413 silicon dioxide increases expression ISO Map4k4 (Mus musculus) 6480464 Silicon Dioxide results in increased expression of MAP4K4 mRNA CTD PMID:23221170 sodium arsenate increases expression ISO Map4k4 (Mus musculus) 6480464 sodium arsenate results in increased expression of MAP4K4 mRNA CTD PMID:30953684 sodium arsenite increases expression ISO MAP4K4 (Homo sapiens) 6480464 sodium arsenite results in increased expression of MAP4K4 mRNA CTD PMID:24431212 sodium arsenite decreases expression ISO Map4k4 (Mus musculus) 6480464 sodium arsenite results in decreased expression of MAP4K4 mRNA CTD PMID:18812580 Soman increases expression EXP 6480464 Soman results in increased expression of MAP4K4 mRNA CTD PMID:19281266 sulfates multiple interactions ISO MAP4K4 (Homo sapiens) 6480464 [Soot co-treated with Sulfates] affects the methylation of MAP4K4 promoter CTD PMID:25395096 sulfates affects methylation ISO MAP4K4 (Homo sapiens) 6480464 Sulfates affects the methylation of MAP4K4 promoter CTD PMID:25395096 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of MAP4K4 mRNA] CTD PMID:31150632 tetrachloromethane increases expression ISO Map4k4 (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of MAP4K4 mRNA CTD PMID:31919559 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of MAP4K4 mRNA CTD PMID:31150632 tetrachloromethane multiple interactions ISO Map4k4 (Mus musculus) 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of MAP4K4 mRNA CTD PMID:30517762 tetraphene multiple interactions ISO Map4k4 (Mus musculus) 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MAP4K4 mRNA CTD PMID:27858113 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of MAP4K4 mRNA CTD PMID:23411599 and PMID:34492290 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of MAP4K4 mRNA CTD PMID:25729387 topotecan increases expression EXP 6480464 Topotecan results in increased expression of MAP4K4 mRNA CTD PMID:25729387 tributylstannane decreases expression ISO MAP4K4 (Homo sapiens) 6480464 tributyltin results in decreased expression of MAP4K4 mRNA CTD PMID:27678064 trichostatin A increases expression ISO MAP4K4 (Homo sapiens) 6480464 trichostatin A results in increased expression of MAP4K4 mRNA CTD PMID:24935251 and PMID:26272509 trichostatin A multiple interactions ISO MAP4K4 (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAP4K4 mRNA CTD PMID:27188386 troglitazone increases expression ISO Map4k4 (Mus musculus) 6480464 troglitazone results in increased expression of MAP4K4 mRNA CTD PMID:17569031 tungsten decreases expression ISO Map4k4 (Mus musculus) 6480464 Tungsten results in decreased expression of MAP4K4 mRNA CTD PMID:30912803 valproic acid decreases methylation ISO MAP4K4 (Homo sapiens) 6480464 Valproic Acid results in decreased methylation of MAP4K4 gene CTD PMID:29154799 valproic acid affects splicing EXP 6480464 Valproic Acid affects the splicing of MAP4K4 mRNA CTD PMID:29427782 valproic acid decreases expression ISO MAP4K4 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of MAP4K4 mRNA CTD PMID:23179753 more ... valproic acid increases expression ISO MAP4K4 (Homo sapiens) 6480464 Valproic Acid results in increased expression of MAP4K4 mRNA CTD PMID:26272509 valproic acid affects expression ISO MAP4K4 (Homo sapiens) 6480464 Valproic Acid affects the expression of MAP4K4 mRNA CTD PMID:25979313 vanadium atom decreases expression ISO MAP4K4 (Homo sapiens) 6480464 Vanadium results in decreased expression of MAP4K4 mRNA CTD PMID:19000753 vanadium(0) decreases expression ISO MAP4K4 (Homo sapiens) 6480464 Vanadium results in decreased expression of MAP4K4 mRNA CTD PMID:19000753 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of MAP4K4 mRNA CTD PMID:19015723 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of MAP4K4 mRNA CTD PMID:20566332 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of MAP4K4 mRNA CTD PMID:23034163 vincristine increases expression ISO MAP4K4 (Homo sapiens) 6480464 Vincristine results in increased expression of MAP4K4 mRNA CTD PMID:23649840 vorinostat decreases expression ISO MAP4K4 (Homo sapiens) 6480464 vorinostat results in decreased expression of MAP4K4 mRNA CTD PMID:27188386
